content_image/231951.jpg
## Notes to the financial statements for the financial year ended 31 March 2014 continued 

## Note 38.3 Market risk continued 

## Equity price risk 

The table below indicates the equity markets to which the Consolidated Entity had significant exposure at 31 March on its non- trading investment portfolio excluding interests in associates and joint ventures. The effect on equity (as a result of a change in the fair value of equity instruments held as available for sale at 31 March) and the income statement due to a reasonably possible change in equity prices, with all other variables held constant, is as follows: 

<img src='content_image/231951.jpg'>

